Contemporary outcomes after surgery and medical treatment in patients with severe aortic stenosis registry-2

Conditions

Aortic stenosis

Takeji Y, Taniguchi T, Morimoto T, Shirai S, Kitai T, Tabata H, Ohno N, Murai R, Osakada K, Murata K, Nakai M, Tsuneyoshi H, Tada T, Amano M, Watanabe S, Shiomi H, Watanabe H, Yoshikawa Y, Nishikawa R, Obayashi Y, Yamamoto K, Toyofuku M, Tatsushima S, Kanamori N, Miyake M, Nakayama H, Nagao K, Izuhara M, Nakatsuma K, Inoko M, Fujita T, Kimura M, Ishii M, Usami S, Nakazeki F, Togi K, Inuzuka Y, Ando K, Komiya T, Ono K, Minatoya K, Kimura T, CURRENT AS registry-2 Investigators.

2026-05-26

10.1007/s12928-026-01303-0

Availability of transcatheter aortic valve implantation across hospitals and differences in strategies and clinical outcomes in patients with severe aortic stenosis.

Takeji Y, Taniguchi T, Morimoto T, Shirai S, Kitai T, Tabata H, Ohno N, Murai R, Osakada K, Murata K, Nakai M, Tsuneyoshi H, Tada T, Amano M, Watanabe S, Shiomi H, Watanabe H, Yoshikawa Y, Nishikawa R, Obayashi Y, Yamamoto K, Toyofuku M, Tatsushima S, Kanamori N, Miyake M, Nakayama H, Nagao K, Izuhara M, Nakatsuma K, Inoko M, Fujita T, Kimura M, Ishii M, Usami S, Nakazeki F, Togi K, Inuzuka Y, Ando K, Komiya T, Ono K, Minatoya K, Kimura T, CURRENT AS registry-2 Investigators.

2024-11-283 citations

10.1007/s12928-024-01054-w

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who are diagnosed as severe aortic valve stenosis (aortic valve area less than 1.0cm2, mean gradient greater than 40 mm Hg, or aortic jet velocity greater than 4.0 m/s) from 2018 to 2023 by transthoracic echocardiography.

Exclusion criteria

Exclusion criteria: Prosthetic valve stenosis History of percutaneous balloon aortic valvuloplasty

Design outcomes

Primary

Measure	Time frame
A composite of aortic valve-related death and heart failure hospitalization	—

Secondary

Measure	Time frame
all cause death, cardiovascular death, noncardiovascular death, aortic valve related death, heart failure hospitalization, sudden death, stroke, life threatening/disabling bleeding, emerging symptoms related to AS	—

Countries

Japan

Contacts

Public ContactYasuaki Takeji Tomohiko Taniguchi

Kyoto University Hospital Department of Cardiovascular Medicine

ytakeji@kuhp.kyoto-u.ac.jp075-751-4255

Outcome results